BELLU, LUISA

BELLU, LUISA  

Università di Padova  

Mostra records
Risultati 1 - 6 di 6 (tempo di esecuzione: 0.011 secondi).
Titolo Data di pubblicazione Autori Rivista Serie Titolo libro
Clinical outcome of an alternative fotemustine schedule in elderly patients with recurrent glioblastoma: a mono-institutional retrospective study 2016 Lombardi, GiuseppeBellu, LuisaPambuku, ArdiDella Puppa, AlessandroD’Avella, DomenicoZagonel, Vittorina + JOURNAL OF NEURO-ONCOLOGY - -
Effectiveness of antiangiogenic drugs in glioblastoma patients: A systematic review and meta-analysis of randomized clinical trials 2017 LOMBARDI, GIUSEPPEPAMBUKU, ARDIBELLU, LUISADELLA PUPPA, ALESSANDRODENARO, LUCAZAGONEL, VITTORINA + CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY - -
Good tolerability of maintenance temozolomide in glioblastoma patients after severe hematological toxicity during concomitant radiotherapy and temozolomide treatment: report of two cases 2018 Lombardi, GiuseppeCACCESE, MARIOBellu, LuisaPambuku, ArdiBerti, FrancoGardiman, Marina PDenaro, LucaZagonel, Vittorina + ANTI-CANCER DRUGS - -
Regorafenib compared with lomustine in patients with relapsed glioblastoma (REGOMA): a multicentre, open-label, randomised, controlled, phase 2 trial 2019 Bellu L.Pambuku A.Indraccolo S.Gardiman M. P.Zagonel V. + THE LANCET ONCOLOGY - -
Comparison between18F-Dopa and 18F-Fet PET/CT in patients with suspicious recurrent high grade glioma: A literature review and our experience 2019 Evangelista L.Cuppari L.Bellu L.Caccese M.Zagonel V.Lombardi G. + CURRENT RADIOPHARMACEUTICALS - -
Definition of the Prognostic Role of MGMT Promoter Methylation Value by Pyrosequencing in Newly Diagnosed IDH Wild-Type Glioblastoma Patients Treated with Radiochemotherapy: A Large Multicenter Study 2022 Mario CacceseLuisa BelluFrancesco CavallinMatteo FassanVittorina ZagonelLombardi Giuseppe + CANCERS - -